Advertisement

Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience

  • Ilavarasi Vanidassane
  • Ajay GogiaEmail author
  • Vinod Raina
  • Ritu Gupta
Correspondence
  • 2 Downloads

Dear Editor,

Breast cancer is the most common malignancy among Indian women. With the growing population of breast cancer survivors, the oncologists are confronted with plethora of treatment (chemotherapy, radiotherapy) related adverse effects like fatigue, cardiac toxicities, sexual dysfunction, and second malignancies. A SEER data reported an incidence of 1.8% acute myeloid leukemia (AML) among breast cancer survivors treated with chemotherapy after a period of 10 years follow up [ 1]. Data of treatment related AML (tAML) in breast cancer survivors from our country is limited [ 2]. Hence, we conducted a retrospective analysis of 7 cases of tAML following breast cancer treatment in medical oncology department of BRA-IRCH from 2006 to 2017. The baseline characteristics and outcome are tabulated in Table  1. The median age of diagnosis of tAML was 60 years. All 7 cases received adjuvant chemotherapy, out of which 5 received 5-fluorouracil 500 mg/m 2, epirubicin 75 mg/m 2and...

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

Institute ethical clearance was obtained for the retrospective study.

References

  1. 1.
    Martin MG, Welch JS, Luo J, Ellis MJ, Graubert TA, Walter MJ (2009) Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study. Breast Cancer Res Treat 118(3):593–598CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Bhatia P, Das R, Ahluwalia J, Malhotra P, Varma N, Varma S, Sharma SC, Garewal G (2009) Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India. Indian J Pathol Microbiol 52(2):167–170CrossRefGoogle Scholar
  3. 3.
    Valentini CG, Fianchi L, Voso MT, Caira M, Leone G, Pagano L (2011) Incidence of acute myeloid leukemia after breast cancer. Mediterr J Hematol Infect Dis 3(1):e2011069CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Hershman D, Neugut AI, Jacobson JS (2007) Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 99(3):196–205CrossRefGoogle Scholar
  5. 5.
    Park MJ, Park HY, Ahn HJ, Choi W, Paik KH (2009) Secondary hematological malignancies after breast cancer chemotherapy. Leuk Lymphoma 46(8):1183–1188CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2019

Authors and Affiliations

  • Ilavarasi Vanidassane
    • 1
  • Ajay Gogia
    • 1
    Email author
  • Vinod Raina
    • 2
  • Ritu Gupta
    • 3
  1. 1.Department of Medical OncologyAIIMSNew DelhiIndia
  2. 2.Department of Medical OncologyFortis Memorial Research InstituteGurugramIndia
  3. 3.Lab OncologyIRCHNew DelhiIndia

Personalised recommendations